These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1636055)
1. Monoisoamyl meso-2,3-dimercaptosuccinate: interaction with metallothionein-bound cadmium in vitro and evidence of active transport into renal and hepatic cells in vivo. Tasende MS; Gale GR; Smith AB; Jones MM; Singh PK Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):323-39. PubMed ID: 1636055 [TBL] [Abstract][Full Text] [Related]
2. Enhanced mobilization of hepatic cadmium in mice upon coadministration of an N, N-disubstituted dithiocarbamate and an alkyl monoester of dimercaptosuccinate. Walker EM; Smith AB; Gale GR; Jones MM Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):121-4. PubMed ID: 1626122 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of diethyldithiocarbamate, dimercaptosuccinate, and diethylenetriaminepentaacetate on organ distribution and excretion of cadmium. Gale GR; Atkins LM; Walker EM; Smith AB Ann Clin Lab Sci; 1983; 13(1):33-44. PubMed ID: 6301355 [TBL] [Abstract][Full Text] [Related]
4. Evidence of active transport of cadmium complexing dithiocarbamates into renal and hepatic cells in vivo. Gale GR; Smith AB; Jones MM; Singh PK Pharmacol Toxicol; 1992 Dec; 71(6):452-6. PubMed ID: 1480554 [TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats. Wang XP; Chan HM; Goyer RA; Cherian MG Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114 [TBL] [Abstract][Full Text] [Related]
6. Distribution and retention of cadmium in metallothionein I and II null mice. Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD Toxicol Appl Pharmacol; 1996 Feb; 136(2):260-8. PubMed ID: 8619234 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of amphipathic dithiocarbamates in intracellular cadmium mobilization and in modulation of hepatic and renal metallothionein in cadmium pre-exposed rat. Tandon SK; Prasad S; Singh S; Agarwal DK Chem Biol Interact; 1998 Jul; 114(3):161-75. PubMed ID: 9839629 [TBL] [Abstract][Full Text] [Related]
8. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Vestergaard P; Shaikh ZA Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377 [TBL] [Abstract][Full Text] [Related]
10. Induction of hepatic and renal metallothionein synthesis by ferric nitrilotriacetate in mice: the role of MT as an antioxidant. Min KS; Morishita F; Tetsuchikawahara N; Onosaka S Toxicol Appl Pharmacol; 2005 Apr; 204(1):9-17. PubMed ID: 15781289 [TBL] [Abstract][Full Text] [Related]
11. Metallothionein-null and wild-type mice show similar cadmium absorption and tissue distribution following oral cadmium administration. Liu Y; Liu J; Klaassen CD Toxicol Appl Pharmacol; 2001 Sep; 175(3):253-9. PubMed ID: 11559024 [TBL] [Abstract][Full Text] [Related]
12. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity. Moffatt P; Plaa GL; Denizeau F Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476 [TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Chan HM; Zhu LF; Zhong R; Grant D; Goyer RA; Cherian MG Toxicol Appl Pharmacol; 1993 Nov; 123(1):89-96. PubMed ID: 8236266 [TBL] [Abstract][Full Text] [Related]
14. Effects of hepatic disorder on the fate of cadmium in rats. Tanaka K Dev Toxicol Environ Sci; 1982; 9():237-49. PubMed ID: 7053969 [TBL] [Abstract][Full Text] [Related]
15. Effects of diethyldithiocarbamate and N-methyl-N-dithiocarboxyglucamine on murine hepatic cadmium-metallothionein in vitro. Gale GR; Smith AB; Atkins LM; Jones MM Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):423-34. PubMed ID: 2997889 [TBL] [Abstract][Full Text] [Related]
16. Effect of erythropoiesis on splenic cadmium-metallothionein level following an injection of CdCl2 in mice. Min KS; Ohyanagi N; Ohta M; Onosaka S; Tanaka K Toxicol Appl Pharmacol; 1995 Oct; 134(2):235-40. PubMed ID: 7570600 [TBL] [Abstract][Full Text] [Related]
17. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein. Min KS; Onosaka S; Tanaka K Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681 [TBL] [Abstract][Full Text] [Related]
18. Effect of chelators, monoisoamyl meso-2,3-dimercaptosuccinate and N-(4-methylbenzyl)-4-O-(beta-D-galactopyranosyl)-D-glucamine-N-carbodit hioate, on cadmium and essential element levels in mice. Eybl V; Kotyzová D; Koutenský J; Jones MM; Singh PK Analyst; 1995 Mar; 120(3):855-7. PubMed ID: 7741241 [TBL] [Abstract][Full Text] [Related]
19. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats. Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262 [TBL] [Abstract][Full Text] [Related]
20. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate. Jones MM; Singh PK; Basinger MA; Gale GR; Smith AB; Harris WR Chem Res Toxicol; 1994; 7(3):367-73. PubMed ID: 8075368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]